Leucine-rich repeat kinase 2 (LRRK2): an update on the potential therapeutic target for Parkinson’s disease

Abstract excerpt

Mutations in Leucine-rich repeat kinase 2 (LRRK2) are a risk factor for and a cause of sporadic and familial Parkinson’s disease (PD), respectively. These mutations are some of the most common genetic contributors to PD and render the kinase hyperactive. Increasingly within the past decade, there has been substantial effort investigating LRRK2 as a target for therapeutics in preclinical studies, and currently,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Parkinson's Disease Mechanisms and Treatments
• Share to Plant biochemistry and biosynthesis
• Share to Plant Gene Expression Analysis